Nathan Treybeck
Stock Analyst at Wells Fargo
(0.78)
# 3,916
Out of 4,504 analysts
65
Total ratings
28.2%
Success rate
-3.9%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Nathan Treybeck
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RMD ResMed | Rated: Hold | $227 → $225 | $203.87 | +10.36% | 3 | Jul 8, 2026 | |
| PRCT PROCEPT BioRobotics | Rated: Buy | $34 | $20.89 | +62.76% | 25 | Jul 2, 2026 | |
| LMAT LeMaitre Vascular | Maintained: Hold | $93 → $94 | $102.74 | -8.51% | 7 | Feb 26, 2026 | |
| IRTC iRhythm Holdings | Maintained: Buy | $225 → $200 | $116.13 | +72.22% | 19 | Feb 20, 2026 | |
| ITGR Integer Holdings | Downgraded: Hold | $132 → $80 | $93.68 | -14.60% | 11 | Oct 23, 2025 |
ResMed
Jul 8, 2026
Rated: Hold
Price Target: $227 → $225
Current: $203.87
Upside: +10.36%
PROCEPT BioRobotics
Jul 2, 2026
Rated: Buy
Price Target: $34
Current: $20.89
Upside: +62.76%
LeMaitre Vascular
Feb 26, 2026
Maintained: Hold
Price Target: $93 → $94
Current: $102.74
Upside: -8.51%
iRhythm Holdings
Feb 20, 2026
Maintained: Buy
Price Target: $225 → $200
Current: $116.13
Upside: +72.22%
Integer Holdings
Oct 23, 2025
Downgraded: Hold
Price Target: $132 → $80
Current: $93.68
Upside: -14.60%